rs3798577

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000125.4(ESR1):​c.*1029T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.456 in 398,584 control chromosomes in the GnomAD database, including 41,644 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 15622 hom., cov: 33)
Exomes 𝑓: 0.46 ( 26022 hom. )

Consequence

ESR1
NM_000125.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.111

Publications

116 publications found
Variant links:
Genes affected
ESR1 (HGNC:3467): (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020]
ESR1 Gene-Disease associations (from GenCC):
  • estrogen resistance syndrome
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.503 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESR1NM_000125.4 linkc.*1029T>C 3_prime_UTR_variant Exon 8 of 8 ENST00000206249.8 NP_000116.2 P03372-1G4XH65

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESR1ENST00000206249.8 linkc.*1029T>C 3_prime_UTR_variant Exon 8 of 8 1 NM_000125.4 ENSP00000206249.3 P03372-1

Frequencies

GnomAD3 genomes
AF:
0.454
AC:
68935
AN:
151978
Hom.:
15623
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.430
Gnomad AMI
AF:
0.456
Gnomad AMR
AF:
0.460
Gnomad ASJ
AF:
0.439
Gnomad EAS
AF:
0.425
Gnomad SAS
AF:
0.520
Gnomad FIN
AF:
0.409
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.472
Gnomad OTH
AF:
0.452
GnomAD4 exome
AF:
0.458
AC:
112769
AN:
246488
Hom.:
26022
Cov.:
0
AF XY:
0.458
AC XY:
57250
AN XY:
124940
show subpopulations
African (AFR)
AF:
0.431
AC:
3096
AN:
7184
American (AMR)
AF:
0.436
AC:
3240
AN:
7438
Ashkenazi Jewish (ASJ)
AF:
0.437
AC:
4036
AN:
9242
East Asian (EAS)
AF:
0.417
AC:
9548
AN:
22892
South Asian (SAS)
AF:
0.528
AC:
1604
AN:
3036
European-Finnish (FIN)
AF:
0.431
AC:
8970
AN:
20830
Middle Eastern (MID)
AF:
0.447
AC:
579
AN:
1294
European-Non Finnish (NFE)
AF:
0.469
AC:
74199
AN:
158196
Other (OTH)
AF:
0.458
AC:
7497
AN:
16376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3525
7050
10576
14101
17626
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.453
AC:
68972
AN:
152096
Hom.:
15622
Cov.:
33
AF XY:
0.454
AC XY:
33773
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.430
AC:
17834
AN:
41480
American (AMR)
AF:
0.460
AC:
7042
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.439
AC:
1525
AN:
3470
East Asian (EAS)
AF:
0.425
AC:
2189
AN:
5154
South Asian (SAS)
AF:
0.520
AC:
2511
AN:
4828
European-Finnish (FIN)
AF:
0.409
AC:
4325
AN:
10586
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.472
AC:
32061
AN:
67956
Other (OTH)
AF:
0.455
AC:
961
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2026
4051
6077
8102
10128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
646
1292
1938
2584
3230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.467
Hom.:
19396
Bravo
AF:
0.454
Asia WGS
AF:
0.479
AC:
1665
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.66
DANN
Benign
0.80
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3798577; hg19: chr6-152421130; COSMIC: COSV52805170; API